Sida 1 från 100 resultat
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
FIELD
The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine.
BACKGROUND
Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is related to a method of treating or preventing hyperlipidemia. Particularly, the present invention is related to a method of treating or preventing hyperlipidemia with caffeamide derivatives.
2. The Prior Arts
Diabetes
BACKGROUND
In 2004, it was estimated that over 75 million Americans had one or more forms of cardiovascular disease (CVD). Coronary heart disease (CHD) and coronary artery disease (CAD) are the most common types of CVD. CHD and CAD occur when coronary arteries that supply blood to the heart become
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compounds having inhibitory activity against the biosynthesis of triglycerides and inhibitory activity against the secretion of lipoprotein containing apolipoprotein B, and prophylactic or therapeutic agents for
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to novel multibinding compounds (agents) that inhibit microsomal triglyceride transferase protein (MTP) and to pharmaceutical compositions comprising such compounds. Accordingly, the multibinding compounds and
BACKGROUND OF INVENTION
The use of aldose reductase inhibitors (ARIs) for the treatment of diabetic complications is well known. The complications arise from elevated levels of glucose in tissues such as the nerve, kidney, retina and lens that enters the polyol pathway and is converted to sorbitol
BACKGROUND OF INVENTION
The use of aldose reductase inhibitors (ARIs) for the treatment of diabetic complications is well known. The complications arise from elevated levels of glucose in tissues such as the nerve, kidney, retina and lens that enters the polyol pathway and is converted to sorbitol
FIELD OF THE INVENTION
The invention relates to the field of medicine, such as the use of exendins, exendin agonists, and exendin analog agonists to lower plasma lipid levels and improve cardiovascular health in patients.
BACKGROUND OF THE INVENTION
Research from experimental animals, laboratory
BACKGROUND OF THE INVENTION
The present invention is directed toward bivalent ligands effective for blocking or inhibiting acyl-CoA: cholesterol O-acyltransferase enzyme (hereinafter, ACAT) which is a major regulator of cholesterol metabolism in cells. The blocking or inhibition of ACAT is useful in
BACKGROUND OF THE INVENTION
The present invention is directed toward bivalent ligands effective for blocking or inhibiting acyl-CoA; cholesterol O-acyltransferase enzyme (hereinafter, ACAT) which is a major regulator of cholesterol metabolism in cells. The blocking or inhibition of ACAT is useful in
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2010/008944, filed Dec. 14, 2010, which claims benefit of Korean Patent Application No. 10-2010-0004901, filed Jan. 19, 2010.
FIELD OF THE
FIELD OF THE INVENTION
The invention relates to compositions that can ameliorate or prevent hyperlipemia and are useful as dietary supplements (e.g., health drinks). These compositions contain yeast cells obtainable by growth in electromagnetic fields with specific frequencies and field